British journal of hospital medicine 1997-01-01

Opioid analgesics.

A R Rushton, J R Sneyd

Index: Br. J. Hosp. Med. 57(3) , 105-6, (1997)

Full Text: HTML

Abstract

This article discusses recent developments in opioid pharmacology. Selective activity at different opioid receptors promises, but has not yet provided, a strong analgesic without opioid side-effects. The startling pharmacokinetic profile of the new esterase-metabolized intravenous opioid, remifentanil, is reflected in the rapid onset of effect and short, predictable recovery, independent of duration of infusion.

Related Compounds

  • Meptazinol HCl

Related Articles:

Bis(9)-(-)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice.

2013-03-01

[Pharmacol. Biochem. Behav. 104 , 138-43, (2013)]

Reflex activity caused by laryngoscopy and intubation is obtunded differently by meptazinol, nalbuphine and fentanyl.

2007-01-01

[Eur. J. Anaesthesiol. 24(1) , 53-8, (2007)]

Lack of sensitization during place conditioning in rats is consistent with the low abuse potential of tramadol.

2002-08-23

[Neurosci. Lett. 329(1) , 25-8, (2002)]

Design, synthesis, and bioavailability evaluation of coumarin-based prodrug of meptazinol.

2005-11-15

[Bioorg. Med. Chem. Lett. 15(22) , 4953-6, (2005)]

Synthesis and relative bioavailability of meptazinol benzoyl esters as prodrugs.

2005-05-16

[Bioorg. Med. Chem. Lett. 15(10) , 2607-9, (2005)]

More Articles...